Dr. Toby Christopher Campbell, MD

Dr. Campbell practices at University Health Services - Madison (Highland Ave) in Madison, Wisconsin.

Dr. Campbell's NPI, 1700802220, was assigned on July 15, 2006. Dr. Campbell graduated from UVA School of Medicine in 2001. Dr. Campbell's Wisconsin license number on file is 45236.

Dr. Campbell's primary practice is University Health Services - Madison (Highland Ave), at 600 Highland Ave, Madison, WI 53792. The practice phone is (608) 265-1978.

Dr. Campbell's primary practice is University Health Services - Madison (Highland Ave) in Madison, Wisconsin. Dr. Campbell is also affiliated with University Hospital. The medical group on file is UW Health. Dmand AI also links Dr. Campbell to 2 more hospitals, 1 hospice and 1 medical group, each named with a free account. Dr. Campbell's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Campbell practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Campbell's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Campbell is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Campbell's licenses on file in 3 states: Wisconsin, Florida and Illinois.

Dmand AI lists lung cancer among the conditions Dr. Campbell treats.

CMS data shows 845 Medicare services from Dr. Campbell across 6 procedure codes in 2024, for 195 Medicare patients. Medicare paid $39,186 for them.

CMS counts 195 Medicare patients who saw Dr. Campbell in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have cancer, and 66% have high blood pressure. 15% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Campbell's median patient age at 72, with 54% women.

In 2024, Dr. Campbell wrote 774 Medicare Part D claims for 146 patients. 71% of them were for generic drugs. CMS names the drug for 563 of them, across 17 drugs with 11 or more claims each, at $1,679,497 in total drug cost. In 2023, CMS named 395 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Campbell for performance year 2024, reported as part of a group. Dr. Campbell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Campbell as offering telehealth.

Dmand AI links 56 papers to Dr. Campbell, published from 2008 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Palliative Care, Communication and Physician-Patient Relations. Dr. Campbell has published most often in J Palliat Med. Dr. Campbell's most frequent co-authors are Margaret L. Schwarze, MD, Michael John Nabozny, MD and Rachel Ann Rodenbach, MD.

Dmand AI links Dr. Campbell to 5 clinical trials. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Communication. University of Wisconsin, Madison sponsors the most, 3.

CMS Open Payments shows 22 general payments to Dr. Campbell from 6 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 47% of the total. Heron Therapeutics, Inc. paid the most, $7,274.

Dmand AI lists 9 awards for Dr. Campbell, most recently Family-Centered Care Award, UW Health in 2019. Dr. Campbell serves on ASCO Supportive Oncology and NCCN Palliative Care Panel.

Dr. Campbell graduated from UVA School of Medicine in 2001. Dr. Campbell is a member of AAHPM, ASCO, International Association for the Study of Lung Cancer and Palliative Care Research Cooperative Group (PCRC).

Dr. Campbell is in network with 20 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.